Abstract
Gamma-aminobutyric acid transaminase (GABA-T) deficiency is a rare, autosomal recessive disorder characterized by severe psychomotor retardation, early-onset epileptic encephalopathy, intractable seizures, hypotonia, and hyperreflexia. The disease is caused by mutation in the 4-aminobutyrate aminotransferase (ABAT) gene, which encodes an enzyme involved in GABA catabolism. In this chapter, a 10-year follow-up of GABA-T deficiency in a rare case of a long-term survivor patient is discussed. The patient showed a progression of clinical phases with increasing age. In infancy, the patient developed psychomotor retardation and recurrent encephalopathic episodes associated with febrile illness. In early childhood, the patient presented with refractory involuntary and hyperkinetic movements and dystonic hypertonicity. In childhood, the patient gradually progressed into the chronic stable phase of the condition. Magnetic resonance imaging demonstrated high signal intensity on diffusion-weighted images involving the internal and external capsules and cerebral white matter in infancy which disappeared gradually by the age of 3 years, and showed subsequently diffuse brain atrophy in childhood. Using proton magnetic resonance spectroscopy, GABA levels in the basal ganglia were shown to be markedly elevated at the age of 1–2 years, and subsequently decreased with increasing age (toward 5 years). These findings suggest that the encephalopathic episodes in infancy and clinical severity of involuntary and hyperkinetic movements may be correlated with levels of GABA in the basal ganglia. The high levels of GABA in the cerebrospinal fluid remained unaltered, whereas levels of GABA in the serum decreased during childhood. Further investigation of long-term clinical surveillance may improve the understanding of GABA-T deficiency.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Dracopoulos A, Widjaja E, Raybaud C, Westall CA, Snead OC 3rd (2010) Vigabatrin-associated reversible MRI signal changes in patients with infantile spasms. Epilepsia 51:1297–1304
Jaeken J, Casaer P, de Cock P et al (1984) Gamma-aminobutyric acid-transaminase deficiency: a newly recognized inborn error of neurotransmitter metabolism. Neuropediatrics 15:165–169
Jansen EE, Vogel KR, Salomons GS et al (2016) Correlation of blood biomarkers with age informs pathomechanisms in succinic semialdehyde dehydrogenase deficiency (SSADHD), a disorder of GABA metabolism. J Inherit Metab Dis 39:795–800
Kilb W (2012) Development of the GABAergic system from birth to adolescence. Neuroscientist 18:613–630
Koenig MK, Hodgeman R, Riviello JJ et al (2017) Phenotype of GABA-transaminase deficiency. Neurology 88:1919–1924
Louro P, Ramos L, Robalo C et al (2016) Phenotyping GABA transaminase deficiency: a case description and literature review. J Inherit Metab Dis 39:743–747
Novotny EJ Jr, Fulbright RK, Pearl PL, Gibson KM, Rothman DL (2003) Magnetic resonance spectroscopy of neurotransmitters in human brain. Ann Neurol 54(Suppl 6):S25–S31
Parviz M, Vogel K, Gibson KM, Pearl PL (2014) Disorders of GABA metabolism: SSADH and GABA-transaminase deficiencies. J Pediatr Epilepsy 3:217–227
Peyster RG, Sussman NM, Hershey BL et al (1995) Use of ex vivo magnetic resonance imaging to detect onset of vigabatrin-induced intramyelinic edema in canine brain. Epilepsia 36:93–100
Provencher SW (2001) Automatic quantitation of localized in vivo 1H spectra with LCModel. NMR Biomed 14:260–264
Tsuji M, Aida N, Obata T et al (2010) A new case of GABA transaminase deficiency facilitated by proton MR spectroscopy. J Inherit Metab Dis 33:85–90
Van Hove JLK, Thomas JA (2014) Disorders of glycine, serine, GABA, and proline metabolism. In: Blau N, Duran M, Gibson KM, Dionisi-Vici C (eds) Physician’s guide to the diagnosis, treatment, and follow-up of inherited metabolic diseases. Springer, Berlin, Heidelberg, pp 63–83
Ziyeh S, Berlis A, Korinthenberg R, Spreer J, Schumacher M (2002) Selective involvement of the globus pallidus and dentate nucleus in succinic semialdehyde dehydrogenase deficiency. Pediatr Radiol 32:598–600
Acknowledgement
This work was supported by Japan Society for the Promotion of Science (JSPS) KAKENHI Grant Number 26461843.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Additional information
Communicated by: Avihu Boneh, MD, PhD, FRACP
Appendices
Authors’ Contributions
K.I. wrote the manuscript and provided medical care for the patient; Y.T. and M.T. provided medical care for the patient; M.T. performed the analysis of magnetic resonance spectroscopy and interpreted the results; N.A. interpreted magnetic resonance images; T.G. approved the final manuscript. All authors read and approved the final version of the manuscript.
Corresponding Author
Kazushi Ichikawa.
Conflict of Interest
Kazushi Ichikawa, Megumi Tsuji, Yu Tsuyusaki, Moyoko Tomiyasu, Noriko Aida, and Tomohide Goto declare that they have no conflict of interest.
Funding
Japan Society for the Promotion of Science (JSPS) KAKENHI (Grant Number 26461843) [Aida, Goto, Tsuyusaki].
Compliance with Ethics Guideline
Informed Consent
All procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation (institutional and national) and with the Helsinki Declaration of 1975, as revised in 2000. Informed consent was obtained from the patient’s parents for being included in the study.
Rights and permissions
Copyright information
© 2018 Society for the Study of Inborn Errors of Metabolism (SSIEM)
About this chapter
Cite this chapter
Ichikawa, K., Tsuji, M., Tsuyusaki, Y., Tomiyasu, M., Aida, N., Goto, T. (2018). Serial Magnetic Resonance Imaging and 1H-Magnetic Resonance Spectroscopy in GABA Transaminase Deficiency: A Case Report. In: Morava, E., Baumgartner, M., Patterson, M., Rahman, S., Zschocke, J., Peters, V. (eds) JIMD Reports, Volume 43. JIMD Reports, vol 43. Springer, Berlin, Heidelberg. https://doi.org/10.1007/8904_2018_95
Download citation
DOI: https://doi.org/10.1007/8904_2018_95
Received:
Revised:
Accepted:
Published:
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-662-58613-6
Online ISBN: 978-3-662-58614-3
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)